Intensive Care, Royal Papworth Hospital NHS Foundation Trust Theatres Critical Care and Anaesthetics, Cambridge, UK.
Institute of Clinical Physiology National Research Council, Pisa, Italy.
Int J Artif Organs. 2021 Nov;44(11):854-860. doi: 10.1177/03913988211051395. Epub 2021 Oct 13.
This was a pilot study to determine the utility of daily lung ultrasound (LUS) in patients requiring veno-venous extracorporeal membrane oxygenation (VV-ECMO) for acute respiratory distress syndrome (ARDS).
This was a prospective, observational study.
The study took place in the intensive care unit at Royal Papworth Hospital in Cambridge, UK.
We recruited adult patients receiving VV-ECMO for ARDS.
All patients received a lung computed tomography (CT) scan and LUS on admission. Bedside chest radiography (CXR) and LUS were done on a daily basis until patients were decannulated.
Daily LUS aeration scores were calculated according to the appearance of four defined patterns. An independent radiologist calculated corresponding scores for CT and CXR, retrospectively. These were checked for correlation with LUS aeration scores. There were statistically significant correlations between LUS versus CT ( = 0.868, = 0.002) and LUS versus CXR ( = 0.498, = 0.018) with good agreement and no evidence of proportional bias. LUS was able to detect 13.5% of pleural effusions and 54.2% of pneumothorax that were not picked up on CXR.In most of the patients who were weaned off VV-ECMO, a progressive reduction of LUS aeration scores corresponding to lung re-aeration was observed.
LUS correlated with findings on CT and CXR for quantifying lung aeration and the clinical presentation of patients. LUS also picked up more pleural effusions and pneumothorax than CXR. Together with traditional imaging techniques, the routine use of LUS should be considered for this patient group.
本研究旨在探讨肺部超声(LUS)在急性呼吸窘迫综合征(ARDS)患者接受静脉-静脉体外膜肺氧合(VV-ECMO)治疗中的应用价值。
前瞻性观察性研究。
英国剑桥皇家Papworth医院重症监护病房。
纳入接受 VV-ECMO 治疗的 ARDS 成年患者。
所有患者入院时均行肺部 CT 扫描和 LUS 检查。床边胸部 X 线摄影(CXR)和 LUS 每日进行,直至患者脱机。
根据 4 种特定模式的外观计算每日 LUS 通气评分。一位独立的放射科医生对 CT 和 CXR 进行回顾性评分,并与 LUS 通气评分进行相关性分析。LUS 与 CT( = 0.868, = 0.002)和 LUS 与 CXR( = 0.498, = 0.018)之间具有统计学显著相关性,一致性良好,不存在比例偏差。LUS 能够检测到 CXR 未检出的 13.5%胸腔积液和 54.2%气胸。大多数接受 VV-ECMO 脱机的患者,LUS 通气评分逐渐降低,提示肺部复张。
LUS 与 CT 和 CXR 用于定量评估肺通气和患者的临床表现具有相关性。LUS 还能比 CXR 检出更多胸腔积液和气胸。与传统影像学技术联合使用,LUS 应常规用于此类患者。